David Larsen
Stock Analyst at BTIG
(1.97)
# 3,111
Out of 5,084 analysts
88
Total ratings
33.33%
Success rate
-3.26%
Average return
Main Sectors:
Stocks Rated by David Larsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HQY HealthEquity | Reiterates: Buy | $130 | $95.43 | +36.23% | 5 | Dec 4, 2025 | |
| VEEV Veeva Systems | Reiterates: Buy | $340 | $242.28 | +40.33% | 4 | Nov 21, 2025 | |
| LFMD LifeMD | Maintains: Buy | $18 → $10 | $3.78 | +164.55% | 4 | Nov 18, 2025 | |
| EVH Evolent Health | Maintains: Buy | $20 → $16 | $4.01 | +299.00% | 7 | Nov 7, 2025 | |
| ASTH Astrana Health | Maintains: Buy | $50 → $45 | $22.83 | +97.11% | 2 | Nov 7, 2025 | |
| LFST LifeStance Health Group | Maintains: Buy | $8 → $9 | $6.46 | +39.43% | 1 | Nov 6, 2025 | |
| HIMS Hims & Hers Health | Reiterates: Buy | $85 | $40.02 | +112.39% | 2 | Nov 4, 2025 | |
| BTSG BrightSpring Health Services | Maintains: Buy | $30 → $41 | $35.14 | +16.68% | 3 | Oct 29, 2025 | |
| TOI The Oncology Institute | Reiterates: Buy | $7 | $3.25 | +115.72% | 1 | Oct 21, 2025 | |
| CYRX Cryoport | Maintains: Buy | $10 → $15 | $9.80 | +53.06% | 4 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $2.68 | - | 4 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $25 | $20.46 | +22.19% | 3 | Jul 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $80 | $51.31 | +55.92% | 2 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $28 | $24.01 | +16.62% | 4 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $31 | $22.40 | +38.39% | 3 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $290 → $260 | $224.92 | +15.60% | 2 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7 | $2.52 | +178.33% | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $7 | $1.05 | +566.67% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.25 | - | 2 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $39.54 | - | 7 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $0.73 | - | 1 | Jun 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $23.92 | +46.32% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $7.78 | - | 3 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $4.12 | - | 1 | Jan 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $199.19 | - | 6 | Nov 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $170 → $160 | $814.18 | -80.35% | 2 | May 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $73.13 | - | 5 | Apr 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $76.75 | +10.75% | 3 | Feb 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $34 → $23 | $2.55 | +801.96% | 1 | Nov 2, 2017 |
HealthEquity
Dec 4, 2025
Reiterates: Buy
Price Target: $130
Current: $95.43
Upside: +36.23%
Veeva Systems
Nov 21, 2025
Reiterates: Buy
Price Target: $340
Current: $242.28
Upside: +40.33%
LifeMD
Nov 18, 2025
Maintains: Buy
Price Target: $18 → $10
Current: $3.78
Upside: +164.55%
Evolent Health
Nov 7, 2025
Maintains: Buy
Price Target: $20 → $16
Current: $4.01
Upside: +299.00%
Astrana Health
Nov 7, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $22.83
Upside: +97.11%
LifeStance Health Group
Nov 6, 2025
Maintains: Buy
Price Target: $8 → $9
Current: $6.46
Upside: +39.43%
Hims & Hers Health
Nov 4, 2025
Reiterates: Buy
Price Target: $85
Current: $40.02
Upside: +112.39%
BrightSpring Health Services
Oct 29, 2025
Maintains: Buy
Price Target: $30 → $41
Current: $35.14
Upside: +16.68%
The Oncology Institute
Oct 21, 2025
Reiterates: Buy
Price Target: $7
Current: $3.25
Upside: +115.72%
Cryoport
Sep 18, 2025
Maintains: Buy
Price Target: $10 → $15
Current: $9.80
Upside: +53.06%
Sep 5, 2025
Reiterates: Neutral
Price Target: n/a
Current: $2.68
Upside: -
Jul 7, 2025
Maintains: Buy
Price Target: $41 → $25
Current: $20.46
Upside: +22.19%
Jun 2, 2025
Upgrades: Buy
Price Target: $80
Current: $51.31
Upside: +55.92%
Mar 31, 2025
Upgrades: Buy
Price Target: $28
Current: $24.01
Upside: +16.62%
Nov 11, 2024
Maintains: Buy
Price Target: $30 → $31
Current: $22.40
Upside: +38.39%
Nov 1, 2024
Maintains: Buy
Price Target: $290 → $260
Current: $224.92
Upside: +15.60%
Sep 17, 2024
Initiates: Buy
Price Target: $7
Current: $2.52
Upside: +178.33%
May 9, 2024
Maintains: Buy
Price Target: $11 → $7
Current: $1.05
Upside: +566.67%
Apr 1, 2024
Downgrades: Neutral
Price Target: n/a
Current: $5.25
Upside: -
Nov 3, 2023
Downgrades: Neutral
Price Target: n/a
Current: $39.54
Upside: -
Jun 24, 2022
Initiates: Neutral
Price Target: n/a
Current: $0.73
Upside: -
Apr 28, 2022
Initiates: Buy
Price Target: $35
Current: $23.92
Upside: +46.32%
Nov 22, 2021
Downgrades: Neutral
Price Target: n/a
Current: $7.78
Upside: -
Jan 7, 2021
Initiates: Neutral
Price Target: n/a
Current: $4.12
Upside: -
Nov 16, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $199.19
Upside: -
May 29, 2018
Maintains: Market Perform
Price Target: $170 → $160
Current: $814.18
Upside: -80.35%
Apr 4, 2018
Upgrades: Outperform
Price Target: n/a
Current: $73.13
Upside: -
Feb 9, 2018
Maintains: Outperform
Price Target: $90 → $85
Current: $76.75
Upside: +10.75%
Nov 2, 2017
Maintains: Market Perform
Price Target: $34 → $23
Current: $2.55
Upside: +801.96%